Accelrys acquires QUMAS

Published: 10-Dec-2013
Regulatory Finance Digital

Adds end-to-end document and process management compliance solutions to portfolio


Accelrys has acquired Ireland-based QUMAS, a provider of Cloud-based and on-premises enterprise compliance software that supports regulatory and quality operations in life sciences and other regulated industries.

No financial details have been revealed.

Accelrys said the acquisition extends its informatics portfolio with the addition of end-to-end document and process management compliance solutions.

'As Accelrys continues to extend its research, laboratory and manufacturing informatics capabilities to deliver first-in-class scientific innovation lifecycle management (SILM) solutions, we're delighted to welcome the QUMAS team and the extensive compliance, quality and regulatory expertise they bring to our company,' said Accelrys' President and CEO Max Carnecchia. 'Integrating QUMAS solutions into the Accelrys product portfolio will provide a single-vendor SILM solution that is already in high demand for product lifecycle management into the critical compliance and quality management arena for science-based process industries.'

QUMAS has been refining the documentation of compliance with global mandates (including FDA and GxP standards) in regulated industries for 20 years. The firm provides an electronic document management application with related R&D submission and QA documentation packages. The business process management applications include CAPA (corrective action/preventive action), audit, change control, deviation, complaint and other critical process packages offering pre-defined and pre-tested software configurations addressing common compliance challenges.

Research, laboratory and manufacturing informatics applications such as the Accelrys ELN (Electronic Lab Notebook), Accelrys LIMS (Laboratory Information Management System),  Accelrys LES ( Lab Execution System) and Accelrys Discoverant for Operational Intelligence will function as data sources as well as integration points for the compliance and quality business systems managed by QUMAS.

Available as SaaS (Software as a Service), private Cloud or on-premises deployments, QUMAS compliance and quality solutions scale to thousands of users and millions of documents, while also fully supporting collaboration with third parties.

  • Companies:
  • Biovia
See more

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Research & Development

Digital by design

Read more
With research productivity top of the agenda, Dennis Curran, Director of Product Management, BIOVIA, Dassault Systèmes (previously Accelrys), discusses how to modernise a laboratory in five key steps

Trending Articles

  1. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  2. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  3. Merck's Welireg approved for cancers associated with von Hippel-Lindau disease in China The once-daily drug is the first HIF-2α to be approved in China, exhibiting a 49% objective response rate (ORR)
  4. Vetter strengthens senior management team for growth Three new managing directors to support global sustainable development

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Research & Development

Digital by design

With research productivity top of the agenda, Dennis Curran, Director of Product Management, BIOVIA, Dassault Systèmes (previously Accelrys), discusses how to modernise a laboratory in five key steps
Digital

Accelrys announces mobile multi-media lab application

Offers accurate, realtime multi-media capture at the bench for scientists
Hi Tech Manufacturing

Dassault Systemes and Accelrys to merge

Accelrys launches information management and collaboration workspace called ScienceCloud
You need to be a subscriber to read this article.
Click here to find out more.
Digital

Working smarter with predictive science

Optimising a molecular lead series is a critical step in transitioning initial hit compounds from screening into potent, selective and bioavailable agents suitable for progression to preclinical development and eventual consideration as candidate drugs. Advanced modelling and simulation solutions for both small molecule and macromolecule-based drug design can help to investigate and test hypotheses <i>in silico</i> prior to costly experimentation, thus reducing the time and expense involved in bringing new drugs to market
Digital

Accelrys expands process management and compliance suite

With the addition of a Laboratory Information Management System (LIMS)
Digital

Why CGT manufacturers should automate the production process

Cell and gene therapies can be highly complex and time-consuming to produce at scale; full robotic automation could help biologics manufacturers to make processes more space, personnel and cost efficient
Manufacturing

CDMO Adragos Pharma acquires aseptic fill-finish manufacturing expert, Baccinex

Baccinex has significant knowledge in sterile fill-finish processes for both lyophilised and liquid vials
Subscribe now